Document is current
Any future updates will be listed below
-
Authors
Fairlie, Gage M. J.
Nguyen, Kha M.
Nam, Sung-Eun
Shaw, Alexandria L. https://orcid.org/0000-0002-0615-599X
Parson, Matthew A. H. https://orcid.org/0000-0001-6270-559X
Shariati, Hannah R.
Wang, Xinyin https://orcid.org/0009-0004-9053-458X
Jenkins, Meredith L.
Gong, Michael
Burke, John E. https://orcid.org/0000-0001-7904-9859
Yip, Calvin K. https://orcid.org/0000-0003-1779-9501
-
Funding
Funding for this research was provided by:
Gouvernement du Canada | Canadian Institutes of Health Research (PJT-168907)
Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (AWD-007855)
- License Information
-
More Information
Article History
Received: 14 June 2024
Accepted: 23 December 2024
First Online: 8 January 2025
Competing interests
: J.E.B. reports personal fees from Scorpion Therapeutics and Reactive Therapeutics and research contracts from Novartis and Calico Life Sciences. All other authors declare no competing interests.
